Impacto del vitíligo en la calidad de vida de pacientes adultos: Un estudio evaluativo
Artículo de Revisión
Abstract
Resumen: Este estudio evaluó el impacto del vitíligo en la calidad de vida de pacientes adultos, abordando aspectos físicos, psicológicos y sociales de la enfermedad. Se destacó la influencia negativa en la autoestima, confianza en sí mismo y relaciones sociales. La estigmatización y discriminación social fueron aspectos relevantes. Se recomienda una atención integral que considere las implicaciones psicológicas y sociales, además de las médicas. Es crucial proporcionar apoyo emocional y educativo, fomentar la conciencia pública y promover el apoyo social. Se subraya la importancia de programas de apoyo psicológico y grupos de autoayuda. Se sugiere investigar terapias dirigidas, tratamientos combinados y factores ambientales. Se concluye que una atención integral puede mejorar la calidad de vida de los pacientes y reducir el impacto negativo del vitíligo.
Vitiligo. Quality of life. Impact. Mental health. Stigmatization
References
Huggins RH, Schwartz RA, Janniger CK. Childhood vitiligo. Cutis. 2007 Apr;79(4):277–80.
Simons RE, Zevy DL, Jafferany M. Psychodermatology of vitiligo: Psychological impact and consequences. Dermatol Ther. 2020 May 4;33(3).
Seneschal J, Harris JE, Le Poole IC, Passeron T, Speeckaert R, Boniface K. Editorial: Immunology of Vitiligo. Front Immunol. 2021 Jun 24;12.
Huggins RH, Schwartz RA, Janniger CK. Vitiligo. Acta Dermatovenerol Alp Pannonica Adriat. 2005 Dec;14(4):137–42, 144–5.
Khaitan BK, Sindhuja T. Autoimmunity in vitiligo: Therapeutic implications and opportunities. Autoimmun Rev. 2022 Jan;21(1):102932.
Manoj R, Singh S, Kothari R, Gupta A. Vitiligo. J Am Acad Dermatol. 2024 May;90(5):1106–14.
Speeckaert R, Lambert J, Bulat V, Belpaire A, Speeckaert M, van Geel N. Autoimmunity in Segmental Vitiligo. Front Immunol. 2020 Oct 27;11.
Silverberg NB. Pediatric Vitiligo. Pediatr Clin North Am. 2014 Apr;61(2):347–66.
Le Poole C, Boissy RE. Vitiligo. Semin Cutan Med Surg. 1997 Mar;16(1):3–14.
Matz H, Tur E. Vitiligo1. In: Environmental Factors in Skin Diseases. Basel: KARGER; 2007. p. 78–102.
Okoro U. Vitiligo. Cutis. 2023 Feb 1;111(2).
van Geel N, Speeckaert R. Segmental Vitiligo. Dermatol Clin. 2017 Apr;35(2):145–50.
Thakur V, Bishnoi A, Vinay K, Kumaran SM, Parsad D. Vitiligo: Translational research and effective therapeutic strategies. Pig-ment Cell Melanoma Res. 2021 Jul 5;34(4):814–26.
Leung AKC, Lam JM, Leong KF, Hon KL. Vitiligo: An Updated Narrative Review. Curr Pediatr Rev. 2021 May;17(2):76–91.
Kussainova A, Kassym L, Akhmetova A, Glushkova N, Sabirov U, Adilgozhina S, et al. Vitiligo and anxiety: A systematic review and meta-analysis. PLoS One. 2020 Nov 10;15(11):e0241445.
Böhm M, Schunter JA, Fritz K, Salavastru C, Dargatz S, Augustin M, et al. S1 Guideline: Diagnosis and therapy of vitiligo. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2022 Mar 4;20(3):365–78.
Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. New discoveries in the pathogenesis and classification of vitiligo. J Am Acad Dermatol. 2017 Jul;77(1):1–13.
Bergqvist C, Ezzedine K. Vitiligo: A focus on pathogenesis and its therapeutic implications. J Dermatol. 2021 Mar 6;48(3):252–70.
Spritz RA, Santorico SA. The Genetic Basis of Vitiligo. Journal of Investigative Dermatology. 2021 Feb;141(2):265–73.
LeWitt TM, Kundu R V. Vitiligo. JAMA Dermatol. 2021 Sep. 1;157(9):1136.
Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. The Lancet. 2015 Jul;386(9988):74–84.
Bergqvist C, Ezzedine K. Vitiligo: A Review. Dermatology. 2020;236(6):571–92.
Frisoli ML, Essien K, Harris JE. Vitiligo: Mechanisms of Pathogenesis and Treatment. Annu Rev Immunol. 2020 Apr 26;38(1):621–48.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is a human-readable summary of (and not a substitute for) the license.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
